Pharmaceutical Service Strategies for Asthma During Pandemic of COVID-19

LI Meng; YANG Chen; YU Jie; LAN Gaoshuang; SHANG Jie; LI Zhengxiang; YUAN Hengjie

doi:10.14009/j.issn.1672-2124.2020.05.004

您当前的位置：

首页 >

文章列表页 >

Pharmaceutical Service Strategies for Asthma During Pandemic of COVID-19

更新时间：2022-10-08

- Pharmaceutical Service Strategies for Asthma During Pandemic of COVID-19
- Vol. 20, Issue 5, Pages: 526-527(2020)
- 作者机构：
  
  天津医科大学总医院药剂科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.05.004
  CLC： R562.25
- Published：2020，
扫描看全文
[1]李蒙,杨晨,禹洁,蓝高爽,尚杰,李正翔,袁恒杰.新型冠状病毒肺炎疫情期间哮喘疾病的药学服务策略[J].中国医院用药评价与分析,2020,20(05):526-527+532.

LI Meng, YANG Chen, YU Jie, et al. Pharmaceutical Service Strategies for Asthma During Pandemic of COVID-19. [J]. 20(5):526-527(2020)
[1]李蒙,杨晨,禹洁,蓝高爽,尚杰,李正翔,袁恒杰.新型冠状病毒肺炎疫情期间哮喘疾病的药学服务策略[J].中国医院用药评价与分析,2020,20(05):526-527+532. DOI： 10.14009/j.issn.1672-2124.2020.05.004.

LI Meng, YANG Chen, YU Jie, et al. Pharmaceutical Service Strategies for Asthma During Pandemic of COVID-19. [J]. 20(5):526-527(2020) DOI： 10.14009/j.issn.1672-2124.2020.05.004.

摘要

针对新型冠状病毒肺炎（COVID-19）疫情

为积极防控疫情

阻断病毒传播

全国各地采取了多种防控隔离措施。哮喘为常见的慢性疾病

药师应对哮喘患者给予关注

在疫情期间加强与患者的沟通

预防严重急性呼吸综合征冠状病毒2型（severe acute respiratory syndrome coronavirus 2

SARS-CoV-2）感染的同时做好哮喘的疾病控制。对于感染SARS-CoV-2的哮喘患者

药师应予以特殊的药学监护。本文结合COVID-19的防控形势

总结了特殊时期哮喘疾病的管理及药学服务策略。

Abstract

In response to the outbreak of COVID-19

various prevention and quarantine measures have been taken throughout the country in order to actively prevent and control the epidemic and stop the transmission of the virus.Asthma is a kind of common chronic disease. The clinical pharmacists should pay close attention to asthma patients

strengthen communication with patients during the outbreak

prevent severe acute respiratory syndrome coronavirus 2（SARS-CoV-2） infection and control the disease. Pharmacists should provide special pharmaceutical care for asthma patients infected with SARS-CoV-2. This thesis summarizes the management and pharmaceutical service strategies of asthma in a special period in combination with the prevention and control situation of COVID-19.

关键词

新型冠状病毒肺炎哮喘药学服务策略

Keywords

COVID-19AsthmaPharmaceutical service strategies

references

查看原文

Views

211

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Progress of Antiviral Research of Arbidol

Systematic Review of Efficacy and Safety of Lopinavir/Ritonavir in Patients with COVID-19

Application of Traditional Chinese Medicine Injection in the Treatment of COVID-19

Mechanism of Ganlu Xiaodu Decoction on COVID-19 Treatment Based on Network Pharmacology

Analysis on Application of Antiviral Drugs in 51 Patients with COVID-19

Related Author

BAI Jiawei

MA Chengtai

WEI Jie

WU Miao

DU Xianjin

WU Xiayang

WU Xiuping

BAI Xue

Related Institution

Dept.of Emergency, Renmin Hospital of Wuhan University

Dept.of Critical Care Medicine, Renmin Hospital of Wuhan University

Dept.of Pharmacy,Xiamen Children’s Hospital

Dept.of Pharmacy,Guang’anmen Hospital of China Academy of Chinese Medical Sciences

Dept. of Pharmacy, China-Japan Friendship Hospital

⁰